{"result": "(\"entity\"<|>WAIKAR SS<|>PERSON<|>Waikar SS is an author of a study on mortality after hospitalization with hyponatremia, contributing to the medical literature on this condition.)\n##\n(\"entity\"<|>MOUNT DB<|>PERSON<|>Mount DB is an author of a study on mortality after hospitalization with hyponatremia, contributing to the medical literature on this condition.)\n##\n(\"entity\"<|>CURHAN GC<|>PERSON<|>Curhan GC is an author of a study on mortality after hospitalization with hyponatremia, contributing to the medical literature on this condition.)\n##\n(\"entity\"<|>VERBALIS JG<|>PERSON<|>Verbalis JG is an author who has written about disorders of body water homeostasis, contributing to the understanding of hyponatremia.)\n##\n(\"entity\"<|>HOORN EJ<|>PERSON<|>Hoorn EJ is an author who has revisited hyponatremia and its clinical implications, contributing to the medical literature on this condition.)\n##\n(\"entity\"<|>ZIETSE R<|>PERSON<|>Zietse R is an author who has contributed to the understanding of hyponatremia and its management in clinical practice.)\n##\n(\"entity\"<|>ANDERSON RJ<|>PERSON<|>Anderson RJ is an author who has conducted a prospective analysis of hyponatremia and its epidemiology.)\n##\n(\"entity\"<|>CHUNG HM<|>PERSON<|>Chung HM is an author who has contributed to the research on hyponatremia and its clinical implications.)\n##\n(\"entity\"<|>KLUGE R<|>PERSON<|>Kluge R is an author who has researched the pathogenetic role of vasopressin in hyponatremia.)\n##\n(\"entity\"<|>SCHRIER RW<|>PERSON<|>Schrier RW is an author who has contributed to the understanding of hyponatremia and its clinical outcomes.)\n##\n(\"entity\"<|>SINGER P<|>PERSON<|>Singer P is an author who has contributed to the ESPEN guidelines on parenteral nutrition, relevant to patients with hyponatremia.)\n##\n(\"entity\"<|>BERGER MM<|>PERSON<|>Berger MM is an author who has contributed to the ESPEN guidelines on parenteral nutrition, relevant to patients with hyponatremia.)\n##\n(\"entity\"<|>VAN DEN BERGHE G<|>PERSON<|>Van den Berghe G is an author who has contributed to the ESPEN guidelines on parenteral nutrition, relevant to patients with hyponatremia.)\n##\n(\"entity\"<|>BIOLO G<|>PERSON<|>Biolo G is an author who has contributed to the ESPEN guidelines on parenteral nutrition, relevant to patients with hyponatremia.)\n##\n(\"entity\"<|>CALDER P<|>PERSON<|>Calder P is an author who has contributed to the ESPEN guidelines on parenteral nutrition, relevant to patients with hyponatremia.)\n##\n(\"entity\"<|>FORBES A<|>PERSON<|>Forbes A is an author who has contributed to the ESPEN guidelines on parenteral nutrition, relevant to patients with hyponatremia.)\n##\n(\"entity\"<|>GOMEZ HOYOS E<|>PERSON<|>Gomez Hoyos E is an author who has researched the morbidity and mortality of hospitalized patients receiving parenteral nutrition and presenting hyponatremia.)\n##\n(\"entity\"<|>MATÍA MARTIN P<|>PERSON<|>Matía Martin P is an author who has researched the morbidity and mortality of hospitalized patients receiving parenteral nutrition and presenting hyponatremia.)\n##\n(\"entity\"<|>ORTOLA BUIGUES A<|>PERSON<|>Ortola Buigues A is an author who has researched the morbidity and mortality of hospitalized patients receiving parenteral nutrition and presenting hyponatremia.)\n##\n(\"entity\"<|>CRESPO HERNANDEZ I<|>PERSON<|>Crespo Hernandez I is an author who has researched the morbidity and mortality of hospitalized patients receiving parenteral nutrition and presenting hyponatremia.)\n##\n(\"entity\"<|>CUESTA HERNANDEZ M<|>PERSON<|>Cuesta Hernandez M is an author who has researched the morbidity and mortality of hospitalized patients receiving parenteral nutrition and presenting hyponatremia.)\n##\n(\"entity\"<|>PEREZ FERRE N<|>PERSON<|>Perez Ferre N is an author who has researched the morbidity and mortality of hospitalized patients receiving parenteral nutrition and presenting hyponatremia.)\n##\n(\"entity\"<|>HYUNSOO OH<|>PERSON<|>HyunSoo Oh is an author who has studied the effects of nasogastric tube feeding on serum sodium levels, relevant to hyponatremia.)\n##\n(\"entity\"<|>YEONOK SUH<|>PERSON<|>YeonOK Suh is an author who has studied the effects of nasogastric tube feeding on serum sodium levels, relevant to hyponatremia.)\n##\n(\"entity\"<|>SUNKYUNG HWANG<|>PERSON<|>SunKyung Hwang is an author who has studied the effects of nasogastric tube feeding on serum sodium levels, relevant to hyponatremia.)\n##\n(\"entity\"<|>WHASOOK SEO<|>PERSON<|>WhaSook Seo is an author who has studied the effects of nasogastric tube feeding on serum sodium levels, relevant to hyponatremia.)\n##\n(\"entity\"<|>CLAYTON JA<|>PERSON<|>Clayton JA is an author who has researched severe hyponatremia in medical in-patients, contributing to the understanding of this condition.)\n##\n(\"entity\"<|>LE JEUNE IR<|>PERSON<|>Le Jeune IR is an author who has researched severe hyponatremia in medical in-patients, contributing to the understanding of this condition.)\n##\n(\"entity\"<|>HALL IP<|>PERSON<|>Hall IP is an author who has researched severe hyponatremia in medical in-patients, contributing to the understanding of this condition.)\n##\n(\"entity\"<|>GILL GV<|>PERSON<|>Gill GV is an author who has studied the characteristics and outcomes of severe hyponatremia, contributing to the medical literature on this condition.)\n##\n(\"entity\"<|>HUDA MSB<|>PERSON<|>Huda MSB is an author who has studied the characteristics and outcomes of severe hyponatremia, contributing to the medical literature on this condition.)\n##\n(\"entity\"<|>WILE D<|>PERSON<|>Wile D is an author who has studied the characteristics and outcomes of severe hyponatremia, contributing to the medical literature on this condition.)\n##\n(\"entity\"<|>BOYD A<|>PERSON<|>Boyd A is an author who has studied the characteristics and outcomes of severe hyponatremia, contributing to the medical literature on this condition.)\n##\n(\"entity\"<|>SKAGEN K<|>PERSON<|>Skagen K is an author who has studied the characteristics and outcomes of severe hyponatremia, contributing to the medical literature on this condition.)\n##\n(\"entity\"<|>WATSON ID<|>PERSON<|>Watson ID is an author who has studied the characteristics and outcomes of severe hyponatremia, contributing to the medical literature on this condition.)\n##\n(\"entity\"<|>CHAWLA A<|>PERSON<|>Chawla A is an author who has researched mortality and serum sodium levels, contributing to the understanding of hyponatremia.)\n##\n(\"entity\"<|>STERNS RH<|>PERSON<|>Sterns RH is an author who has researched mortality and serum sodium levels, contributing to the understanding of hyponatremia.)\n##\n(\"entity\"<|>NIGWEKAR SU<|>PERSON<|>Nigwekar SU is an author who has researched mortality and serum sodium levels, contributing to the understanding of hyponatremia.)\n##\n(\"entity\"<|>CAPPUCCIO JD<|>PERSON<|>Cappuccio JD is an author who has researched mortality and serum sodium levels, contributing to the understanding of hyponatremia.)\n##\n(\"entity\"<|>WALD R<|>PERSON<|>Wald R is an author who has studied the impact of hospital-associated hyponatremia on selected outcomes.)\n##\n(\"entity\"<|>JABER BL<|>PERSON<|>Jaber BL is an author who has studied the impact of hospital-associated hyponatremia on selected outcomes.)\n##\n(\"entity\"<|>PRICE LL<|>PERSON<|>Price LL is an author who has studied the impact of hospital-associated hyponatremia on selected outcomes.)\n##\n(\"entity\"<|>CORONA G<|>PERSON<|>Corona G is an author who has conducted a meta-analysis on moderate hyponatremia and its association with increased mortality risk.)\n##\n(\"entity\"<|>GIULIANI C<|>PERSON<|>Giuliani C is an author who has conducted a meta-analysis on moderate hyponatremia and its association with increased mortality risk.)\n##\n(\"entity\"<|>PARENTI G<|>PERSON<|>Parenti G is an author who has conducted a meta-analysis on moderate hyponatremia and its association with increased mortality risk.)\n##\n(\"entity\"<|>NORELLO D<|>PERSON<|>Norello D is an author who has conducted a meta-analysis on moderate hyponatremia and its association with increased mortality risk.)\n##\n(\"entity\"<|>VERBALIS JG<|>PERSON<|>Verbalis JG is an author who has conducted a meta-analysis on moderate hyponatremia and its association with increased mortality risk.)\n##\n(\"entity\"<|>FORTI G<|>PERSON<|>Forti G is an author who has conducted a meta-analysis on moderate hyponatremia and its association with increased mortality risk.)\n##\n(\"entity\"<|>BALLING L<|>PERSON<|>Balling L is an author who has researched hyponatremia at hospital admission and its predictive value for overall mortality.)\n##\n(\"entity\"<|>GUSTAFSSON F<|>PERSON<|>Gustafsson F is an author who has researched hyponatremia at hospital admission and its predictive value for overall mortality.)\n##\n(\"entity\"<|>GOETZE JP<|>PERSON<|>Goetze JP is an author who has researched hyponatremia at hospital admission and its predictive value for overall mortality.)\n##\n(\"entity\"<|>DALSGAARD M<|>PERSON<|>Dalsgaard M is an author who has researched hyponatremia at hospital admission and its predictive value for overall mortality.)\n##\n(\"entity\"<|>NIELSEN H<|>PERSON<|>Nielsen H is an author who has researched hyponatremia at hospital admission and its predictive value for overall mortality.)\n##\n(\"entity\"<|>BOESGAARD S<|>PERSON<|>Boesgaard S is an author who has researched hyponatremia at hospital admission and its predictive value for overall mortality.)\n##\n(\"entity\"<|>TZOULIS P<|>PERSON<|>Tzoulis P is an author who has conducted a case-control study on hyponatremia as an independent risk factor for inpatient mortality.)\n##\n(\"entity\"<|>BAGKERIS E<|>PERSON<|>Bagkeris E is an author who has conducted a case-control study on hyponatremia as an independent risk factor for inpatient mortality.)\n##\n(\"entity\"<|>BOULOUX P-M<|>PERSON<|>Bouloux P-M is an author who has conducted a case-control study on hyponatremia as an independent risk factor for inpatient mortality.)\n##\n(\"entity\"<|>HOORN EJ<|>PERSON<|>Hoorn EJ is an author who has researched hyponatremia and mortality, contributing to the understanding of this condition.)\n##\n(\"entity\"<|>ZIETSE R<|>PERSON<|>Zietse R is an author who has researched hyponatremia and mortality, contributing to the understanding of this condition.)\n##\n(\"entity\"<|>ZILBERBERG M<|>PERSON<|>Zilberberg M is an author who has studied the epidemiology and outcomes of admission hyponatremia among hospitalized patients.)\n##\n(\"entity\"<|>EXUZIDES A<|>PERSON<|>Exuzides A is an author who has studied the epidemiology and outcomes of admission hyponatremia among hospitalized patients.)\n##\n(\"entity\"<|>SPALDING J<|>PERSON<|>Spalding J is an author who has studied the epidemiology and outcomes of admission hyponatremia among hospitalized patients.)\n##\n(\"entity\"<|>FOREMAN A<|>PERSON<|>Foreman A is an author who has studied the epidemiology and outcomes of admission hyponatremia among hospitalized patients.)\n##\n(\"entity\"<|>JONES A<|>PERSON<|>Jones A is an author who has studied the epidemiology and outcomes of admission hyponatremia among hospitalized patients.)\n##\n(\"entity\"<|>COLBY C<|>PERSON<|>Colby C is an author who has studied the epidemiology and outcomes of admission hyponatremia among hospitalized patients.)\n##\n(\"entity\"<|>SHORR AF<|>PERSON<|>Shorr AF is an author who has studied the epidemiology and outcomes of admission hyponatremia among hospitalized patients.)\n##\n(\"entity\"<|>AYUS JC<|>PERSON<|>Ayus JC is an author who has researched postoperative hyponatremic encephalopathy in menstrual women.)\n##\n(\"entity\"<|>WHEELER JM<|>PERSON<|>Wheeler JM is an author who has researched postoperative hyponatremic encephalopathy in menstrual women.)\n##\n(\"entity\"<|>ARIEF AL<|>PERSON<|>Arief AL is an author who has researched postoperative hyponatremic encephalopathy in menstrual women.)\n##\n(\"entity\"<|>DASTA JF<|>PERSON<|>Dasta JF is an author who has evaluated costs associated with tolvaptan-mediated hospital length of stay reduction among patients with hyponatremia.)\n##\n(\"entity\"<|>CHIONG JR<|>PERSON<|>Chiong JR is an author who has evaluated costs associated with tolvaptan-mediated hospital length of stay reduction among patients with hyponatremia.)\n##\n(\"entity\"<|>CHRISTIAN R<|>PERSON<|>Christian R is an author who has evaluated costs associated with tolvaptan-mediated hospital length of stay reduction among patients with hyponatremia.)\n##\n(\"entity\"<|>LIN J<|>PERSON<|>Lin J is an author who has evaluated costs associated with tolvaptan-mediated hospital length of stay reduction among patients with hyponatremia.)\n##\n(\"entity\"<|>GREENBERG A<|>PERSON<|>Greenberg A is an author who has reported on current treatment practices and outcomes related to hyponatremia.)\n##\n(\"entity\"<|>VERBALIS JG<|>PERSON<|>Verbalis JG is an author who has reported on current treatment practices and outcomes related to hyponatremia.)\n##\n(\"entity\"<|>AMIN AN<|>PERSON<|>Amin AN is an author who has reported on current treatment practices and outcomes related to hyponatremia.)\n##\n(\"entity\"<|>BURST VR<|>PERSON<|>Burst VR is an author who has reported on current treatment practices and outcomes related to hyponatremia.)\n##\n(\"entity\"<|>CHIODO III JA<|>PERSON<|>Chiodo III JA is an author who has reported on current treatment practices and outcomes related to hyponatremia.)\n##\n(\"entity\"<|>CHIONG JR<|>PERSON<|>Chiong JR is an author who has reported on current treatment practices and outcomes related to hyponatremia.)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: . Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild,moderate, and severe hyponatremia. Am J Med. 2009; 122:857-65.\n4. Verbalis JG. Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab. 2003 Dec; 17(4):471-503.\n5. Hoorn EJ, Zietse R. Hyponatremia Revisited: Translating Physiology to Practice. Nephron Physiol. 2008; 108(3):p46-59.\n6. Anderson RJ, Chung HM, kluge R,, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med. 1985; 102.\n7. American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. Clinical Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients. J Parenter Enteral Nutr. 2009; 33:255-9.\n8. Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, et al. ESPEN Guidelines on Parenteral Nutrition: Intensive care. Clin Nutr. 2009 Aug; 28(4):387-400.\n9. Gomez Hoyos E, Matía Martin P, Ortola Buigues A, Crespo Hernandez I, Cuesta Hernandez M, Perez Ferre N, et al. Morbimortality of hospitalized patients receiving parenteral nutrition and presenting hyponatremia. Endocrine Abstr 18th Eur Congr Endocrinol 2016. 41.\n10. HyunSoo Oh, YeonOK Suh, SunKyung Hwang, WhaSook Seo. Effects of nasogastric tube feeding on serum sodium, potassium, and glucose levels. J Nurs Scholarsh. 2005; 37(2):141-7.\n11. Clayton JA, Le Jeune IR, Hall IP. Severe hyponatremia in medical in-patients: aetiology,assessment and outcome. QJM. 2006; 99:505.\n12. Gill GV, Huda MSB, Wile D, Boyd A, Skagen K, Watson ID, et al. Characteristics and outcome of severe hyponatremia- a case control study. Clinical Endocrinol (Oxf). 2006; 65:246-9.\n13. Chawla A, Sterns RH, Nigwekar SU, Cappuccio JD. Mortality and Serum Sodium: Do Patients Die from or with Hyponatremia ? Clin J Am Soc Nephrol. 2011; 6:960-5.\n14. Wald R, Jaber BL, Price LL. Impact of Hospital-Associated Hyponatremia on Selected Outcomes. Arch Intern Med. 2010; 170:294-302.\n15. Corona G, Giuliani C, Parenti G, Norello D, Verbalis JG, Forti G, et al. Moderate Hyponatremia Is Associated with Increased Risk of Mortality: Evidence from a Meta-Analysis. Alisi A, editor. PLoS ONE. 2013 Dec 18; 8(12):e80451.\n16. Balling L, Gustafsson F, Goetze JP, Dalsgaard M, Nielsen H, Boesgaard S, et al. Hyponatremia at Hospital Admission is a Predictor of Overall Mortality. Intern Med J. 2014; 1-20.\n17. Tzoulis P, Bagkeris E, Bouloux P-M. A case-control study of hyponatraemia as an independent risk factor for inpatient mortality. Clin Endocrinol (Oxf). 2014 Sep; 81(3):401-7.\n18. Hoorn EJ, Zietse R. Hyponatremia and Mortality: moving beyond associations. Am J Kidney Dis. 2013;62:139–49.\n19. Hoorn EJ, Zietse R. Hyponatremia and Mortality: How Innocent is the Bystander? Clin J Am Soc Nephrol. 2011 May 1; 6(5):951-3.\n20. Zilberberg M, Exuzides A, Spalding J, Foreman A, Jones A, Colby C, Shorr AF. Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin. 2008; 24:1601-8.\n21. Ayus JC, Wheeler JM, Arief AL. Postoperative hyponatremic encephalopathy in menstrual women. Ann Intern Med. 1992; 117:891-7.\n22. Dasta JF, Chiong JR, Christian R, Lin J. Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate Antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials. Hosp Pr Minneap. 2012; 40(1):7-14.\n23. Greenberg A, Verbalis JG, Amin AN, Burst VR, Chiodo III JA, Chiong JR, et al. Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int [Internet]. 2015 Feb\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>AMERICAN SOCIETY FOR PARENTERAL AND ENTERAL NUTRITION<|>ORGANIZATION<|>The American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) is a professional organization that provides clinical guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients.)\n##\n(\"entity\"<|>HYPOVOLEMIC HYPONATREMIA<|>EVENT<|>Hypovolemic hyponatremia is a condition characterized by low sodium levels in the blood due to a decrease in blood volume, often requiring clinical attention and management.)\n##\n(\"entity\"<|>MORTALITY<|>EVENT<|>Mortality refers to the state of being subject to death, often analyzed in clinical studies to understand the impact of various medical conditions, including hyponatremia.)\n##\n(\"entity\"<|>HYPOVOLEMIA<|>EVENT<|>Hypovolemia is a medical condition where there is a decreased volume of blood in the body, which can lead to various health complications, including hyponatremia.)\n##\n(\"entity\"<|>CLINICAL GUIDELINES<|>EVENT<|>Clinical guidelines are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.)\n##\n(\"entity\"<|>NEPHRON PHYSIOLOGY<|>EVENT<|>Nephron physiology refers to the study of the functional unit of the kidney, which plays a crucial role in maintaining body fluid and electrolyte balance.)\n##\n(\"entity\"<|>ENDOCRINE ABSTR<|>EVENT<|>Endocrine Abstr is a publication that presents abstracts from endocrine-related research, including studies on conditions like hyponatremia.)\n##\n(\"entity\"<|>JOURNAL OF PARENTERAL AND ENTERAL NUTRITION<|>ORGANIZATION<|>The Journal of Parenteral and Enteral Nutrition publishes research and guidelines related to nutritional support for patients, including those with hyponatremia.)\n##\n(\"entity\"<|>CLINICAL NUTRITION<|>ORGANIZATION<|>Clinical Nutrition is a journal that focuses on the science and practice of nutrition in health and disease, including studies on parenteral nutrition.)\n##\n(\"entity\"<|>ANNALS OF INTERNAL MEDICINE<|>ORGANIZATION<|>The Annals of Internal Medicine is a peer-reviewed medical journal that publishes research articles, reviews, and guidelines on various internal medicine topics, including hyponatremia.)\n##\n(\"entity\"<|>PLoS ONE<|>ORGANIZATION<|>PLoS ONE is a peer-reviewed open-access scientific journal that covers primary research from any discipline within science and medicine, including studies on hyponatremia.)\n##\n(\"relationship\"<|>AMERICAN SOCIETY FOR PARENTERAL AND ENTERAL NUTRITION<|>JOURNAL OF PARENTERAL AND ENTERAL NUTRITION<|>A.S.P.E.N. provides clinical guidelines that are published in the Journal of Parenteral and Enteral Nutrition<|>7)\n##\n(\"relationship\"<|>HYPOVOLEMIC HYPONATREMIA<|>MORTALITY<|>Hypovolemic hyponatremia is associated with increased mortality rates in hospitalized patients<|>8)\n##\n(\"relationship\"<|>HYPOVOLEMIA<|>HYPOVOLEMIC HYPONATREMIA<|>Hypovolemia can lead to the development of hypovolemic hyponatremia<|>6)\n##\n(\"relationship\"<|>CLINICAL GUIDELINES<|>HYPOVOLEMIC HYPONATREMIA<|>Clinical guidelines provide recommendations for the management of hypovolemic hyponatremia<|>7)\n##\n(\"relationship\"<|>NEPHRON PHYSIOLOGY<|>HYPOVOLEMIC HYPONATREMIA<|>Nephron physiology is crucial for understanding the mechanisms behind hypovolemic hyponatremia<|>6)\n##\n(\"relationship\"<|>ENDOCRINE ABSTR<|>HYPOVOLEMIC HYPONATREMIA<|>Endocrine Abstr publishes research related to conditions like hypovolemic hyponatremia<|>5)\n##\n(\"relationship\"<|>CLINICAL NUTRITION<|>HYPOVOLEMIC HYPONATREMIA<|>Clinical Nutrition may include studies on the nutritional management of patients with hypovolemic hyponatremia<|>5)\n##\n(\"relationship\"<|>ANNALS OF INTERNAL MEDICINE<|>HYPOVOLEMIC HYPONATREMIA<|>The Annals of Internal Medicine publishes research articles that may address hypovolemic hyponatremia<|>5)\n##\n(\"relationship\"<|>PLoS ONE<|>HYPOVOLEMIC HYPONATREMIA<|>PLoS ONE publishes studies that may include findings on hypovolemic hyponatremia<|>5)\n<|COMPLETE|>"}]}